S&P 500   3,841.47
DOW   30,996.98
QQQ   325.42
Buy Kinder Morgan, Inc While It Still Yields 6.75%
Global stocks sink after China coronavirus resurgence
Biden ordering stopgap help as talks start on big aid plan
After a Post-Earnings Drop, is it Time to Ride PetMed Express?
pixel
Biden's pause on oil cause for big concern in New Mexico
Biden halts border wall building after Trump's final surge
Stocks slip on Wall Street as worldwide rally takes a pause
S&P 500   3,841.47
DOW   30,996.98
QQQ   325.42
Buy Kinder Morgan, Inc While It Still Yields 6.75%
Global stocks sink after China coronavirus resurgence
Biden ordering stopgap help as talks start on big aid plan
After a Post-Earnings Drop, is it Time to Ride PetMed Express?
pixel
Biden's pause on oil cause for big concern in New Mexico
Biden halts border wall building after Trump's final surge
Stocks slip on Wall Street as worldwide rally takes a pause
S&P 500   3,841.47
DOW   30,996.98
QQQ   325.42
Buy Kinder Morgan, Inc While It Still Yields 6.75%
Global stocks sink after China coronavirus resurgence
Biden ordering stopgap help as talks start on big aid plan
After a Post-Earnings Drop, is it Time to Ride PetMed Express?
pixel
Biden's pause on oil cause for big concern in New Mexico
Biden halts border wall building after Trump's final surge
Stocks slip on Wall Street as worldwide rally takes a pause
S&P 500   3,841.47
DOW   30,996.98
QQQ   325.42
Buy Kinder Morgan, Inc While It Still Yields 6.75%
Global stocks sink after China coronavirus resurgence
Biden ordering stopgap help as talks start on big aid plan
After a Post-Earnings Drop, is it Time to Ride PetMed Express?
pixel
Biden's pause on oil cause for big concern in New Mexico
Biden halts border wall building after Trump's final surge
Stocks slip on Wall Street as worldwide rally takes a pause
Log in
CNSX:SL

(SL) Stock Forecast, Price & News

Add
Today's Range N/A
50-Day Range N/A
52-Week Range N/A
VolumeN/A
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Supreme Cannabis Company Inc, formerly Supreme Pharmaceuticals Inc, is a Canada-based company. The Company is focused on developing businesses in the cannabis market, with a specific focus on the wholesale sector of the medical cannabis market in Canada. The Company operates an approximately 342,000 square foot greenhouse facility located in Kincardine, Ontario. The Company's subsidiary is 8528934 Canada Ltd., doing business as 7 ACRES, a licensed producer of medical cannabis. 8528934 Canada Ltd. cultivates medical cannabis at its approximately seven acres (over 342,000 square feet) hybrid greenhouse (the Hybrid Greenhouse) facility in Kincardine, Ontario.

MarketRank™

Overall MarketRank™

0.56 out of 5 stars

Analyst Opinion: 0.0Community Rank: 2.8Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Industry, Sector and Symbol

Stock Exchange CNSX
Industry N/A
Sub-IndustryCannabis
SectorN/A
Current SymbolCNSX:SL
Previous Symbol
CUSIPN/A
CIKN/A
Webwww.supreme.ca
Phone+1-416-6307272
EmployeesN/A

Debt

Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / Cash FlowN/A
Book ValueN/A
Price / BookN/A

Profitability

EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A

Miscellaneous

Outstanding SharesN/A
Market CapN/A
Next Earnings DateN/A
OptionableNot Optionable
30 days | 90 days | 365 days | Advanced Chart

Receive SL News and Ratings via Email

Sign-up to receive the latest news and ratings for SL and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











(SL) (CNSX:SL) Frequently Asked Questions

What stocks does MarketBeat like better than (SL)?

Wall Street analysts have given (SL) a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but (SL) wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

Who are some of (SL)'s key competitors?

Some companies that are related to (SL) include Canopy Growth (WEED), Innovative Industrial Properties (IIPR), MedReleaf Corp. (LEAF.TO) (LEAF), GrowGeneration (GRWG), OrganiGram Holdings Inc. (OGI.TO) (OGI), 22nd Century Group (XXII), Emblem (EMC), Bioventix PLC (BVXP.L) (BVXP), ICC Labs Inc. (ICC.V) (ICC), KushCo (KSHB), General Cannabis (CANN), Terra Tech (TRTC), Grow Capital (GRWC), Leafbuyer Technologies (LBUY) and NSAV (NSAV).
View all of SL's competitors.

What other stocks do shareholders of (SL) own?

Based on aggregate information from My MarketBeat watchlists, some companies that other (SL) investors own include Aurora Cannabis (ACBFF), OrganiGram Holdings Inc. (OGI.TO) (OGI), Smart Cannabis (SCNA), The Green Organic Dutchman Holdings Ltd. (TGOD.TO) (TGOD), Zynerba Pharmaceuticals (ZYNE), NVIDIA (NVDA), Advanced Micro Devices (AMD), (CGC), Cisco Systems (CSCO) and Innovative Industrial Properties (IIPR).

Who are (SL)'s key executives?

(SL)'s management team includes the following people:
  • Michael John La Brier, Chairman of the Board (Age 66)
  • Navdeep S. Dhaliwal, President, Director
  • John Fowler, Chief Executive Officer, Director
  • Dimitre Naoumov, Chief Financial Officer
  • Chander Batra, Chief Information Officer
  • Sony Gokhale, General Counsel
  • Ronald A Factor, Director
  • Scott Walters, Director

What is (SL)'s stock symbol?

(SL) trades on the CNSX under the ticker symbol "SL."

What is (SL)'s official website?

The official website for (SL) is www.supreme.ca.

How can I contact (SL)?

(SL)'s mailing address is 371 Jones Ave, TORONTO, ON M4J 3G5, Canada. The company can be reached via phone at +1-416-6307272.

This page was last updated on 1/23/2021 by MarketBeat.com Staff
Receive Analysts' Upgrades and Downgrades Daily

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.